<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="other">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Indian J Pharmacol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Indian J Pharmacol</journal-id>
      <journal-id journal-id-type="publisher-id">IJPharm</journal-id>
      <journal-title-group>
        <journal-title>Indian Journal of Pharmacology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0253-7613</issn>
      <issn pub-type="epub">1998-3751</issn>
      <publisher>
        <publisher-name>Medknow Publications &amp; Media Pvt Ltd</publisher-name>
        <publisher-loc>India</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">23087519</article-id>
      <article-id pub-id-type="pmc">3469961</article-id>
      <article-id pub-id-type="publisher-id">IJPharm-44-521</article-id>
      <article-id pub-id-type="doi">10.4103/0253-7613.99340</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Drug Watch</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>A rare case of unilateral gynecomastia during antituberculous chemotherapy with isoniazid</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Goud</surname>
            <given-names>B. K. Manjunatha</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
          <xref ref-type="corresp" rid="cor1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Devi</surname>
            <given-names>Oinam Sarsina</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nayal</surname>
            <given-names>Bhavna</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Devaki</surname>
            <given-names>R. N.</given-names>
          </name>
          <xref ref-type="aff" rid="aff4">3</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1">Department of Biochemistry, Ras Al Khaimah Medical and Health Sciences University, Ras Al Khaimah, U.A.E</aff>
      <aff id="aff2"><label>1</label>Department of Nursing, Vidya Nursing College, Udupi, India</aff>
      <aff id="aff3"><label>2</label>Department of Nursing, KMC, Manipal University, Manipal, Karnataka, India</aff>
      <aff id="aff4"><label>3</label>Department of Nursing, JSS Medical College, JSS University, Mysore, Karnataka, India</aff>
      <author-notes>
        <corresp id="cor1"><bold>Correspondence to:</bold> Dr. B. K. Manjunatha Goud, E-mail: <email xlink:href="drmanjunathag@gmail.com">drmanjunathag@gmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>Jul-Aug</season>
        <year>2012</year>
      </pub-date>
      <volume>44</volume>
      <issue>4</issue>
      <fpage>521</fpage>
      <lpage>522</lpage>
      <history>
        <date date-type="received">
          <day>03</day>
          <month>10</month>
          <year>2011</year>
        </date>
        <date date-type="rev-recd">
          <day>25</day>
          <month>3</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>30</day>
          <month>4</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright: &#xA9; Indian Journal of Pharmacology</copyright-statement>
        <copyright-year>2012</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Gynecomastia refers to enlargement of male breast (s) due to benign proliferation of glandular tissue and is caused by excessive estrogen. The etiology may be pathological, pharmacological, or idiopathic reasons. The present report describes a case of gynecomastia due to isoniazid therapy.</p>
      </abstract>
      <kwd-group>
        <title>KEY WORDS</title>
        <kwd>Gynaecomastia</kwd>
        <kwd>hormone</kwd>
        <kwd>isoniazid</kwd>
        <kwd>male</kwd>
        <kwd>tuberculosis</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="sec1-1">
      <title>Introduction</title>
      <p>Gynaecomastia refers to enlargement of male breast (s) due to benign proliferation of glandular tissue. It is caused by excessive estrogen (stimulatory hormone) in the form of increased estrogen/androgen ratio.[<xref ref-type="bibr" rid="ref1">1</xref>] Gynaecomastia may be due to various reasonsandstudies have shown that 25% cases are due to persistent pubertal gynecomastia, 10%-25% are drug-induced and 25% are idiopathic.[<xref ref-type="bibr" rid="ref2">2</xref>]</p>
      <p>Isoniazid has been widely used as an effective drug in all antituberculosis drug regimens. The serious adverse reactions during isoniazid therapy are rare and include hepatitis, peripheral neuropathy, cutaneous reactions and mental changes etc. Although isoniazid has also been reported to cause gynecomastia,[<xref ref-type="bibr" rid="ref2">2</xref>] the cases are fairly rare.[<xref ref-type="bibr" rid="ref3">3</xref>&#x2013;<xref ref-type="bibr" rid="ref6">6</xref>] The present case describes gynecomastia due to isoniazid therapy.</p>
    </sec>
    <sec id="sec1-2">
      <title>Case Report</title>
      <p>A 45-year-old male smoker, nonalcoholic presented with complaints of cough, expectoration, low-grade fever, and decreased appetite. Past history revealed pulmonary tuberculosis two years back and was treated with complete course of antituberculosis treatment. On further evaluation, he was diagnosed to have sputum positive pulmonary tuberculosis. The patient was treated with rifampicin 450 mg, isoniazid 300 mg, pyrazinamide 1500 mg, and ethambutol 800 mg, once daily. Pyrazinamide and ethambutol were stopped after the initial two months. After four months, while on isoniazid and rifampicin, the patient felt mild pain in the left mammary region, which aggravated on touching and on lying on the left side. Two weeks later, the patient noticed a swelling around the left nipple.</p>
      <p>All laboratory investigations such as complete blood count, liver function tests, renal function tests were within normal limits. Chest X-ray revealed a patchy consolidation on right upper lung field.</p>
      <p>On examination, a round lump (5 cm &#xD7; 4 cm) was visible, which was tender, soft and not fixed to underlying tissues. The secondary sexual characters and the external genitalia were evaluated and found to be normal.</p>
      <p>Isoniazid was stopped immediately with a presumptive diagnosis of isoniazid-associated gynecomastia. Antituberculous regimen except for isoniazid was given and his breast swelling and tenderness resolved slowly within 1 month. Patient completed a 9-months course of antituberculous treatment and is now on follow-up.</p>
    </sec>
    <sec sec-type="discussion" id="sec1-3">
      <title>Discussion</title>
      <p>Gynaecomastia is one of the most common breast problems in men and was first described by Paulus Aegineta (AD 625-690), who thought it was due to formation of fat.[<xref ref-type="bibr" rid="ref7">7</xref>] It can occur due to numerous causes including developmental gynecomastia, congenital causes like Klinefelter syndrome, hermaphroditism, enzyme defects of testosterone production, acquired causes such as trauma, infection, torsion (twisted testicles), radiation, mumps, chemotherapy, malignancies such as bronchogenic carcinoma, alcoholism, systemic causes like congenital adrenal hyperplasia, cirrhosis, renal failure, thyrotoxicosis, and medicines. Clinically significant gynecomastia caused by drugs are common and may be due to an impaired balance in the serum estrogen to androgen ratio or a rise in prolactin level.[<xref ref-type="bibr" rid="ref8">8</xref><xref ref-type="bibr" rid="ref9">9</xref>] Isoniazid causes gynecomastia by altering the vitamin B6 complex activation in liver, leading to altered estrogen-androgen metabolism. It has also been postulated that isoniazid probably acts by phenomenon called &#x201C;Refeeding Gynaecomastia,&#x201D; which is supposed to be caused by restoration of weight, gonadotrophin secretion and gonadal functions.[<xref ref-type="bibr" rid="ref10">10</xref>] Awareness regarding isoniazid-induced gynaecomastia would be of great help to the prescribers.</p>
    </sec>
  </body>
  <back>
    <ack>
      <p>All the authors would like to thank Dr. Raguveer C.V, Professor of Pathology and Medical Director, Srinivas Institute of Medical Sciences and Research Institue, Mukka, Mangalore for their valuable guidence and support.</p>
    </ack>
    <fn-group>
      <fn fn-type="supported-by">
        <p><bold>Source of Support:</bold> Nil.</p>
      </fn>
      <fn fn-type="conflict">
        <p><bold>Conflict of Interest:</bold> No.</p>
      </fn>
    </fn-group>
    <ref-list>
      <ref id="ref1">
        <label>1</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Henry</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Molmed</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kenneth</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Reed</surname>
              <given-names>Larsen P</given-names>
            </name>
          </person-group>
          <source>William's Textbook of Endocrinology</source>
          <year>2008</year>
          <edition>11th ed</edition>
          <publisher-name>Saunders Elsevier</publisher-name>
          <fpage>669</fpage>
          <lpage>71</lpage>
        </element-citation>
      </ref>
      <ref id="ref2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Braunstein</surname>
              <given-names>GD</given-names>
            </name>
          </person-group>
          <article-title>Gynecomastia</article-title>
          <source>N Engl J Med</source>
          <year>1993</year>
          <volume>328</volume>
          <fpage>490</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="pmid">8421478</pub-id>
        </element-citation>
      </ref>
      <ref id="ref3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guinet</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Garin</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Morneix</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Gynecomastia in a grave case of pulmonary tuberculosis during isonicotinic acid hydrazide therapy</article-title>
          <source>Lyon Med</source>
          <year>1953</year>
          <volume>188</volume>
          <fpage>281</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="pmid">13070786</pub-id>
        </element-citation>
      </ref>
      <ref id="ref4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bergogne-Berezin</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Nouhouayi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Letonturier</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Thibault</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Tourneur</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Gynecomastia caused by isoniazid: Value of determination of the inactivation phenotype</article-title>
          <source>Nouv Presse Med</source>
          <year>1976</year>
          <volume>5</volume>
          <fpage>213</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="pmid">1264675</pub-id>
        </element-citation>
      </ref>
      <ref id="ref5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Khanna</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Panjabi</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Maurya</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Shah</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Isoniazid associated painful bilateral gynecomastia</article-title>
          <source>Indian J Chest Dis Allied Sci</source>
          <year>2003</year>
          <volume>45</volume>
          <fpage>277</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">12962465</pub-id>
        </element-citation>
      </ref>
      <ref id="ref6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dixit</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Sharma</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Nawal</surname>
              <given-names>CL</given-names>
            </name>
          </person-group>
          <article-title>Gynaecomastia during antituberculosis chemotherapy with isoniazid</article-title>
          <source>J Assoc Physicians India</source>
          <year>2008</year>
          <volume>56</volume>
          <fpage>390</fpage>
          <lpage>1</lpage>
          <pub-id pub-id-type="pmid">18700651</pub-id>
        </element-citation>
      </ref>
      <ref id="ref7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Park</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Lamberty</surname>
              <given-names>BG</given-names>
            </name>
          </person-group>
          <article-title>Gynaecomastia: Have Webster's lesson been ignored?</article-title>
          <source>J R Coll Surg Edinb</source>
          <year>1998</year>
          <volume>43</volume>
          <fpage>89</fpage>
          <lpage>92</lpage>
          <pub-id pub-id-type="pmid">9621528</pub-id>
        </element-citation>
      </ref>
      <ref id="ref8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rodriguez</surname>
              <given-names>Garcia LA</given-names>
            </name>
            <name>
              <surname>Jick</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Risk of gynaecomastia associated with cimetidine, omeprazole and anti ulcer drugs</article-title>
          <source>BMJ</source>
          <year>1994</year>
          <volume>308</volume>
          <fpage>503</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="pmid">8136667</pub-id>
        </element-citation>
      </ref>
      <ref id="ref9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hugues</surname>
              <given-names>FC</given-names>
            </name>
            <name>
              <surname>Gourlot</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Le Jeunne</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Drug induced gynecomastia</article-title>
          <source>Ann Med Interne (Paris)</source>
          <year>2000</year>
          <volume>151</volume>
          <fpage>10</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">10761558</pub-id>
        </element-citation>
      </ref>
      <ref id="ref10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bembo</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Carlson</surname>
              <given-names>HE</given-names>
            </name>
          </person-group>
          <article-title>Gynaecomastia: Its feature, when and how to treat it</article-title>
          <source>Cleve Clin J Med</source>
          <year>2004</year>
          <volume>71</volume>
          <fpage>511</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">15242307</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
